Cell Logic for Dual Coupling of a Single Class of Receptors to G(s) and G(i) Proteins.

Rui‐Ping Xiao

DOI: https://doi.org/10.1161/01.res.87.8.635

IF: 23.213

2000-01-01

Circulation Research

Abstract:HomeCirculation ResearchVol. 87, No. 8Cell Logic for Dual Coupling of a Single Class of Receptors to Gs and Gi Proteins Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBCell Logic for Dual Coupling of a Single Class of Receptors to Gs and Gi Proteins Rui-Ping Xiao Rui-Ping XiaoRui-Ping Xiao From the Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Md. Search for more papers by this author Originally published13 Oct 2000https://doi.org/10.1161/01.RES.87.8.635Circulation Research. 2000;87:635–637Gprotein–coupled receptors mediate transmembrane signal transduction for a variety of hormones, neurotransmitters, chemokines, and synthetic ligands. It had been thought that a given receptor couples only to a single class of heterotrimeric G proteins to achieve signaling selectivity and specificity. As a model system of G protein–coupled receptors, β-adrenergic receptor (βAR) was believed to activate exclusively a Gs-adenylyl cyclase-cAMP-protein kinase A (PKA) signaling cascade. This doctrine, however, has been challenged by recent findings that, although seeming illogical, β2AR dually couples to Gs and Gi proteins in rodent and canine hearts123 (for review, see Reference 4 ). In this issue of Circulation Research, Kilts et al5 present a solid study that provides additional evidence supporting a dual G protein coupling for β2AR and extended the previous finding to several other Gs-coupled receptors in human heart.Gs and Gi DichotomyEarly studies showed that stimulation of β1AR, but not β2AR, induces a relaxant effect,67 a hallmark of cAMP-dependent cardiac modulation. Moreover, β2AR-induced augmentations in intracellular Ca2+ transient and contractility are apparently dissociated from cellular cAMP accumulation and PKA-mediated protein phosphorylation in rat ventricular myocytes, whereas the classic linear Gs-adenylyl cyclase-cAMP-PKA signaling cascade is corroborated for β1AR stimulation.8 These findings provided the first clue that there are some substantial differences between β1AR and β2AR signaling pathways.In search for answers to the anomalous behavior of cardiac β2AR stimulation, recent studies have revealed dichotomous G protein coupling for native β2AR under physiological conditions. Disrupting Gi signaling by pertussis toxin (PTX)–mediated ribosylation enhances β2AR-induced contractile response in rat ventricular myocytes1 and unmasks the β2AR positive inotropic effect in mouse cardiac myocytes, in which Gi signaling fully negates β2AR/Gs-mediated contractile response.2 More recently, photoaffinity labeling of G proteins with [32P]-azidoanilido-GTP in conjunction with immunoprecipitation with antibodies specific for Gαs and Gαi provided direct biochemical evidence that β2AR activates both Gs and Gi (Gαi2 and Gαi3) signaling pathways, whereas β1AR selectively activates Gs in adult mouse cardiac myocytes.2 By photolabeling human atrial membranes with [32P]-azidoanilido-GTP, Kilts et al5 further demonstrated that cardiac Gαi is activated by stimulation of β2AR and several other Gαs-coupled receptors, including histamine, serotonin, and glucagon receptors. Thus, promiscuous G protein coupling seems to be a rather common pattern of receptor–G protein interaction in the physiological context, although this property is not shared by β1AR. These findings raise important questions regarding physiological and pathophysiological relevance of the additional Gi coupling of Gs-coupled receptors.Cell Logic for Receptor Coupling to More Than One G ProteinTransmembrane receptor signaling is a complex biological process orchestrated by a myriad of receptors and G proteins. The interplay of Gs and Gi signaling has been clearly elucidated in crosstalk between different receptor families. For example, stimulation of Gi-coupled muscarinic receptors attenuates the positive inotropic effect of βAR stimulation.910 However, cardiac β2AR and several other Gs-coupled receptors present intriguing cases in which crosstalk occurs between concurrent Gs and Gi signaling pathways originating from a single class of receptors. We are only beginning to appreciate the cellular logic behind the “one receptor, two G protein” signaling mechanism.Although Gi is named for its inhibitory effect on adenylyl cyclase and activation of Gi may counteract the ability of Gs to stimulate adenylyl cyclase, as demonstrated by Kilts et al,5 it is noteworthy that the Gs and Gi interaction is not necessarily confined to the cyclase level.311 Counterintuitively, promiscuous G protein coupling may enhance, rather than compromise, the receptor signaling specificity. This point is perhaps best exemplified by βAR subtype stimulation. In rodent and canine hearts, β1AR stimulation increases phosphorylation of phospholamban, which accelerates Ca2+ sequestration into the sarcoplasmic reticulum, resulting in accelerated cardiac relaxation,46812 and increases phosphorylation of troponin I and C protein,12 which reduces myofilament sensitivity to Ca2+. In contrast, β2AR stimulation modulates specifically L-type Ca2+ channels, bypassing the aforementioned intracellular regulatory proteins.36812 In a direct approach involving on-cell patch-clamp recordings, it has been shown that β2AR stimulation modulates single L-type Ca2+ channel activity only in a local mode (agonist included in pipette solution) but not in a remote mode (agonist added to bathing solution outside the patch), whereas β1AR stimulation does so in either mode.13 Gi activation is essential to the spatial localization and effector selectivity of β2 AR signaling, because inhibiting Gi function with PTX permits a remote β2AR effect on L-type Ca2+ channels13 and a robust increase in phospholamban phosphorylation as well as a markedly accelerated relaxation in response to β2AR stimulation.3Equally appealing, Gi activation may deliver Gs-independent signals through Giα and Giβγ, further enriching receptor signaling diversity. For example, stimulation of the recombinant β2AR transiently expressed in HEK 293 cells activates both Gs and Gi; the latter increases the activity of mitogen-activated protein kinase,14 which plays an important role in regulating chronic cellular processes such as cell growth and cell death.In principle, the aforementioned interplay between Gs and Gi signals could be conducted by two types of receptors coupled to Gs and Gi, respectively. In contrast to the “two receptor, two G protein” system, the beauty of the “one receptor, two G protein” design is that it ensures a proportional activation of the dual G protein signals and affords a spatial and temporal colocalization and coordination of these signals. The delicate balance of Gs and Gi signaling in space and time might be crucial to normal cellular functions.Pathophysiological RelevanceProgrammed cell death or apoptosis has been recently implicated as a consequence of cardiac ischemic/reperfusion injury, contributing to the transition from cardiac hypertrophy to decompensatory heart failure.151617 In vivo and in vitro studies indicate that β1AR and β2AR exhibit distinctly different, even opposing, effects on cardiac myocyte apoptosis. In cultured adult rat cardiac myocytes, stimulation of β1AR, but not β2AR, induces myocyte apoptosis.18 Using a β1β2AR double knockout mouse model in conjunction with adenoviral gene transfer, we have created pure βAR subtype experimental settings and found that β1AR stimulation markedly induces myocyte apoptosis. In contrast, β2AR stimulation activates concurrent apoptotic and survival signals mediated by Gi and Gs, respectively, with the Gi-mediated survival effect predominant (Zhu W-Z, Zheng M, Kolbilka BK, Xiao R-P, unpublished data, 2000). Moreover, activation of β2AR-coupled Gi protects cardiac myocytes from a range of apoptotic assaults, including hypoxia or reactive oxygen species–induced apoptosis (Chesley A, Ohtani S, Asai T, Xiao R-P, Lunberg MS, Lakatta EG, Crow MT, unpublished data, 2000).Chronic stimulation of these βAR subtypes in the heart also elicits strikingly different phenotypes in murine transgenic models. Overexpression of cardiac β1AR by ≈5- to 46-fold induces cardiac hypertrophy, apoptosis, and fibrosis within a few weeks after birth and heart failure within several months.1920 Ironically, overexpression of cardiac β2AR by ≈100- to 200-fold does not induce hypertrophy or heart failure,212223 at least up to the age of 1 year. However, overwhelming expression of β2AR (eg, ≈350- to 1000-fold) induces pathological phenotypes,2223 perhaps caused by a mechanic and metabolic overload (markedly enhanced baseline adenylyl cyclase activity and cardiac contractility) due to spontaneous β2AR activation. Whether the distinct phenotypes of β2AR versus β1AR mouse transgenic models are related to their different G protein coupling merits further investigations.Although activation of β2AR-coupled Gi protects cardiac myocytes against apoptosis, an imbalance of β2AR-initiated Gs and Gi signaling pathways may induce pathological consequences. Chronic heart failure in human and animal models is characterized by a diminished contractile response to βAR stimulation,242526272829 accompanied by a selective downregulation of β1AR (higher β2/β1 ratio)24252627 and an increase in the amount or activity of Gi proteins.2728293031 In light of the Gs and Gi dichotomy, the upregulation of Gi may participate in the defect of βAR inotropic effect in the decompensated failing heart. This idea is supported by recent observations that PTX treatment restores the diminished βAR inotropic response in a rat myocardial infarction heart failure model32 and in myocytes from failing human hearts.33On the basis of these findings, we speculate that the selective downregulation of β1AR and the upregulation of β2AR/Gi signaling in functionally compensated hypertrophic heart or early stage of heart failure may represent a cardiac protective mechanism (eg, against myocyte apoptosis), which slows the progression of cardiomyopathy and contractile dysfunction. However, exaggerated β2AR/Gi signaling may blunt Gs-mediated contractile support, contributing to the phenotype of decompensated heart failure.Therapeutic ImplicationsIt has been highly controversial as to whether enhancing βAR signaling is beneficial or deleterious for the failing heart. The prevalent view is that chronically increasing nonselective βAR stimulation is toxic to the heart, because there is an inverse relationship between the plasma level of norepinephrine and the survival of patients with heart failure34 and because βAR blockade (eg, by β1AR antagonists bisoprolol and metoprolol or a nonselective βAR blocker carvedilol) reduces both the morbidity and mortality in patients with heart failure.35 However, the discovery of a new paradigm of β2AR signaling (ie, the dual G protein coupling), the opposing effects of stimulation of these βAR subtypes on cardiomyocyte apoptosis, and the distinct phenotypes of cardiac-specific overexpression of β1AR versus β2AR underscore the necessity and importance of distinguishing β2AR signaling from that of β1AR in terms of their cardiac functional roles and therapeutic implications.In our opinion, selectively enhancing β2AR signaling may provide a novel therapeutic strategy in the prevention and treatment of chronic heart failure. Indeed, crossing transgenic mice overexpressing cardiac β2AR at appropriate levels (eg, 30-fold) with transgenic mice overexpressing Gqα not only improves the cardiac performance but also reverses hypertrophy in the Gqα overexpression heart failure model,22 although extremely high levels of β2AR overexpression (eg, ≈350- to 1000-fold) fail to rescue the genetic mouse heart failure model.22 Additionally, the beneficial effect of β2AR stimulation in the context of heart failure is clearly supported by the analysis of polymorphisms of β2AR in chronic heart failure patients. The likelihood of earlier aggressive intervention or cardiac transplantation is significantly greater in heart failure patients with Ile164 polymorphism (a Thr to Ile switch at amino acid 164 with reduced β2AR signaling efficacy) relative to patients without the β2AR variant.36In summary, coupling of one receptor to more than one class of G proteins may represent a common property of many Gs-coupled receptors, rather than a unique quality of β2AR. The additional Gi coupling not only confers spatial and temporal control of Gs-stimulated signals, enhancing the receptor signaling specificity, but also enriches signaling diversity by delivering Gs-independent signals. The discovery of the Gs and Gi dichotomy reshapes our current understanding of receptor–G protein interactions in physiological systems. An imbalance of the concurrent Gs and Gi signals may have important pathophysiological relevance and clinic implications.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.I would like to thank Drs Edward G. Lakatta and Heping Cheng for critical discussions and comments.FootnotesCorrespondence to Rui-Ping Xiao, MD, PhD, Laboratory of Cardiovascular Science, Gerontology Research Center, NIA, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224. E-mail [email protected] References 1 Xiao RP, Ji X, Lakatta EG. Functional coupling of the β2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol.1995; 47:322–329.MedlineGoogle Scholar2 Xiao RP, Avdonin P, Zhou YY, Cheng H, Akhter SA, Eschenhagen T, Lefkowitz RJ, Koch WJ, Lakatta EG. Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res.1999; 84:43–52.CrossrefMedlineGoogle Scholar3 Kuschel M, Zhou Y-Y, Cheng H, Zhang SJ, Chen Y, Lakatta EG, Xiao R-P. Gi protein-mediated functional compartmentalization of cardiac β2-adrenergic signaling. J Biol Chem.1999; 274:22048–22052.CrossrefMedlineGoogle Scholar4 Xiao R-P, Cheng H, Zhou Y-Y, Kuschel M, Lakatta EG. Recent advances in cardiac β-adrenergic receptor subtype signal transduction. Circ Res.1999; 85:1092–1100.CrossrefMedlineGoogle Scholar5 Kilts JD, Gerhardt MA, Richardson MD, Sreeram G, Mackensen GB, Grocott HP, White WD, Davis RD, Newman MF, Reves JG, Schwinn DA, Kwatra MM. β2-Adrenergic and several other G protein–coupled receptors in human atrial membranes activate both Gs and Gi. Circ Res.2000; 87:705–709.CrossrefMedlineGoogle Scholar6 Xiao RP, Lakatta EG. β1-Adrenoceptor stimulation and β2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells. Circ Res.1993; 73:286–300.CrossrefMedlineGoogle Scholar7 Kuznetsov V, Pak E, Robinson RB, Steinberg SF. β2-Adrenergic receptor actions in neonatal and adult rat ventricular myocytes. Circ Res.1995; 76:40–52.CrossrefMedlineGoogle Scholar8 Xiao RP, Hohl C, Altschuld R, Jones L, Livingston B, Ziman B, Tantini B, Lakatta EG. β2-Adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem.1994; 269:19151–19156.CrossrefMedlineGoogle Scholar9 Levy MN, Martin PJ, Stuesse SL. Neural regulation of the heart beat. Annu Rev Physiol.1981; 43:443–453.CrossrefMedlineGoogle Scholar10 Gupta RC, Neumann J, Boknik P, Watanabe AM. M2-specific muscarinic cholinergic receptor-mediated inhibition of cardiac regulatory protein phosphorylation. Am J Physiol.1994; 266:H1138–H1144.MedlineGoogle Scholar11 Zhou YY, Cheng H, Bogdanov KY, Hohl C, Altschuld R, Lakatta EG, Xiao RP. Localized cAMP-dependent signaling mediates β2-adrenergic modulation of cardiac excitation-contraction coupling. Am J Physiol.1997; 273:H1611–H1618.CrossrefMedlineGoogle Scholar12 Kuschel M, Zhou Y-Y, Spurgeon HA, Bartel S, Karczewski P, Zhang SJ, Krause E-G, Lakatta EG, Xiao R-P. β2-Adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation.1999; 99:2458–2465.CrossrefMedlineGoogle Scholar13 Chen Y, Xiao R-P, Izu LT, Cheng H, Kuschel M, Spurgeon H, Lakatta EG. Gi-dependent localization of β2-adrenergic receptor signaling to L-type Ca2+ channels. Biophys J. In press.Google Scholar14 Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature.1997; 390:88–91.CrossrefMedlineGoogle Scholar15 Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, Tremblay J, Schwartz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest.1996; 97:2891–2897.CrossrefMedlineGoogle Scholar16 Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW II. Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A.1998; 95:10140–10145.CrossrefMedlineGoogle Scholar17 Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing humans heart. N Engl J Med.1997; 336:1131–1141.CrossrefMedlineGoogle Scholar18 Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation.1999; 100:2210–2212.CrossrefMedlineGoogle Scholar19 Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A.1999; 96:7059–7064.CrossrefMedlineGoogle Scholar20 Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ. Myocardial-directed overexpression of the human β1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol.2000; 32:817–830.CrossrefMedlineGoogle Scholar21 Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ. Enhanced myocardial function in transgenic mice overexpressing the β2-adrenergic receptor. Science.1994; 264:582–586.CrossrefMedlineGoogle Scholar22 Dorn GW II, Tepe NM, Lorenz JN, Koch WJ, Liggett SB. Low- and high-level transgenic expression of β2-adrenergic receptors differentially affect cardiac hypertrophy and function in Gαq-overexpressing mice. Proc Natl Acad Sci U S A.1999; 96:6400–6405.CrossrefMedlineGoogle Scholar23 Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A, Dorn GW II. Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation.2000; 101:1707–1714.CrossrefMedlineGoogle Scholar24 Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med.1982; 307:205–211.CrossrefMedlineGoogle Scholar25 Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson SEB. β1- and β2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure. Circ Res.1986; 59:297–309.LinkGoogle Scholar26 Brodde OE. β1- and β2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev.1991; 43:203–242.MedlineGoogle Scholar27 Kiuchi K, Shannon RP, Komamura K, Cohen DJ, Bianchi C, Homcy CJ, Vatner SF, Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest.1993; 91:907–914.CrossrefMedlineGoogle Scholar28 Gu XH, Kompa AR, Summers RJ. Regulation of β-adrenoceptors in a rat model of cardiac failure: effect of perindopril. J Cardiovasc Pharmacol.1998; 32:66–74.CrossrefMedlineGoogle Scholar29 Hammond HK. Mechanisms for myocardial β-adrenergic receptor desensitization in heart failure. Circulation.1993; 87:652–654.CrossrefMedlineGoogle Scholar30 Eschenhagen T, Mende U, Nose M, Schmitz W, Scholz H, Haverich A, Hirt S, Doring V, Kalmar P, Hoppner W. Increased messenger RNA level of the inhibitory G protein α subunit Giα2 in human end-stage heart failure. Circ Res.1992; 70:688–696.CrossrefMedlineGoogle Scholar31 Bohm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M. Radioimmunochemical quantification of Giα in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Mol Cell Cardiol.1994; 26:133–149.CrossrefMedlineGoogle Scholar32 Kompa AR, Gu XH, Evans BA, Summers RJ. Desensitization of cardiac β-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat: evidence for the role of Gi but not Gs or phosphorylating proteins. J Mol Cell Cardiol.1999; 31:1185–1201.CrossrefMedlineGoogle Scholar33 Brown LA, Harding SE. The effect of pertussis toxin on β-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea-pigs and patients with cardiac failure. Br J Pharmacol.1992; 106:115–122.CrossrefMedlineGoogle Scholar34 Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med.1984; 311:819–823.CrossrefMedlineGoogle Scholar35 Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation.1996; 94:2285–2296.CrossrefMedlineGoogle Scholar36 Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, Walsh RA. The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest.1998; 102:1534–1539.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Liu Z, Tao B, Fan S, Cui S, Pu Y, Qiu L, Xia H and Xu L (2020) Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction, Aging, 10.18632/aging.103320, 12:12, (11603-11622), Online publication date: 18-Jun-2020. Gao Z, Inoue A and Jacobson K (2018) On the G protein-coupling selectivity of the native A2B adenosine receptor, Biochemical Pharmacology, 10.1016/j.bcp.2017.12.003, 151, (201-213), Online publication date: 1-May-2018. Hutter D (2018) The Human Embryo and Its Environment: In Utero Challenges and Physiological Outcomes Development and Environment, 10.1007/978-3-319-75935-7_16, (403-420), . Hutter D, Kingdom J and Jaeggi E (2010) Causes and Mechanisms of Intrauterine Hypoxia and Its Impact on the Fetal Cardiovascular System: A Review, International Journal of Pediatrics, 10.1155/2010/401323, 2010, (1-9), . Xu L, Lai D, Cheng J, Lim H, Keskanokwong T, Backs J, Olson E and Wang Y (2010) Alterations of L-Type Calcium Current and Cardiac Function in CaMKIIδ Knockout Mice, Circulation Research, 107:3, (398-407), Online publication date: 6-Aug-2010. Ryall J and Lynch G (2008) The potential and the pitfalls of β-adrenoceptor agonists for the management of skeletal muscle wasting, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2008.06.003, 120:3, (219-232), Online publication date: 1-Dec-2008. Wu Q, Zhao Z, Sun H, Hao Y, Yan C and Gu S (2008) Oestrogen changed cardiomyocyte contraction and β-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion, Experimental Physiology, 10.1113/expphysiol.2007.041939, 93:9, (1034-1043), Online publication date: 1-Sep-2008. Bruss M, Richter W, Horner K, Jin S and Conti M (2008) Critical Role of PDE4D in β2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts, Journal of Biological Chemistry, 10.1074/jbc.M803306200, 283:33, (22430-22442), Online publication date: 1-Aug-2008. Penner R and Fleig A The Mg2+ and Mg2+-Nucleotide-Regulated Channel-Kinase TRPM7 Transient Receptor Potential (TRP) Channels, 10.1007/978-3-540-34891-7_19, (313-328) Vandeput F, Wolda S, Krall J, Hambleton R, Uher L, McCaw K, Radwanski P, Florio V and Movsesian M (2007) Cyclic Nucleotide Phosphodiesterase PDE1C1 in Human Cardiac Myocytes, Journal of Biological Chemistry, 10.1074/jbc.M703173200, 282:45, (32749-32757), Online publication date: 1-Nov-2007. Brum P, Rolim N, Bacurau A and Medeiros A (2006) Neurohumoral activation in heart failure: the role of adrenergic receptors, Anais da Academia Brasileira de Ciências, 10.1590/S0001-37652006000300009, 78:3, (485-503), Online publication date: 1-Sep-2006. Xu K, Takimoto E and Fedarko N (2006) Activation of (Na++K+)-ATPase induces positive inotropy in intact mouse heart in vivo, Biochemical and Biophysical Research Communications, 10.1016/j.bbrc.2006.08.070, 349:2, (582-587), Online publication date: 1-Oct-2006. Wroblewska B, Wegorzewska I, Bzdega T, Olszewski R and Neale J (2006) Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes, Journal of Neurochemistry, 10.1111/j.1471-4159.2005.03569.x, 96:4, (1071-1077), Online publication date: 1-Feb-2006. Santos I, Sumitame M, Caceres V, Moreira M, Krieger M and Spadari-Bratfisch R (2005) Evidence for two atypical conformations of beta-adrenoceptors and their interaction with Gi proteins, European Journal of Pharmacology, 10.1016/j.ejphar.2005.03.008, 513:1-2, (109-118), Online publication date: 1-Apr-2005. Zhang L (2016) Prenatal Hypoxia and Cardiac Programming, Journal of the Society for Gynecologic Investigation, 10.1016/j.jsgi.2004.09.004, 12:1, (2-13), Online publication date: 1-Jan-2005. Tong H, Bernstein D, Murphy E and Steenbergen C (2005) The role of β‐Adrenergic Receptor Signaling in Cardioprotection, The FASEB Journal, 10.1096/fj.04-3067fje, 19:8, (983-985), Online publication date: 1-Jun-2005. Heubach J, Ravens U and Kaumann A (2004) Epinephrine Activates Both G s and G i Pathways, but Norepinephrine Activates Only the G s Pathway through Human β 2 -Adrenoceptors Overexpressed in Mouse Heart , Molecular Pharmacology, 10.1124/mol.65.5.1313, 65:5, (1313-1322), Online publication date: 1-May-2004. Liang W, Curran P, Hoang Q, Moreland R and Fishman P (2004) Differences in endosomal targeting of human β1- and β2-adrenergic receptors following clathrin-mediated endocytosis, Journal of Cell Science, 10.1242/jcs.00878, 117:5, (723-734), Online publication date: 15-Feb-2004. Hasseldine A, Harper E and Black J (2009) Cardiac-specific overexpression of human β 2 adrenoceptors in mice exposes coupling to both G s and G i proteins , British Journal of Pharmacology, 10.1038/sj.bjp.0705191, 138:7, (1358-1366), Online publication date: 1-Apr-2003. Bae S, Xiao Y, Li G, Casiano C and Zhang L (2003) Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00005.2003, 285:3, (H983-H990), Online publication date: 1-Sep-2003. Tse R, Marroquin B, Dorscheid D and White S (2003) β-Adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells, American Journal of Physiology-Lung Cellular and Molecular Physiology, 10.1152/ajplung.00030.2003, 285:2, (L393-L404), Online publication date: 1-Aug-2003. Xiang Y and Kobilka B (2003) The PDZ-binding motif of the β 2 -adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes , Proceedings of the National Academy of Sciences, 10.1073/pnas.1831718100, 100:19, (10776-10781), Online publication date: 16-Sep-2003. Li G, Xiao Y, Estrella J, Ducsay C, Gilbert R and Zhang L (2016) Effect of Fetal Hypoxia on Heart Susceptibility to Ischemia and Reperfusion Injury in the Adult Rat, Journal of the Society for Gynecologic Investigation, 10.1016/S1071-55760300074-1, 10:5, (265-274), Online publication date: 1-Jul-2003. Liang W, Austin S, Hoang Q and Fishman P (2003) Resistance of the Human β1-Adrenergic Receptor to Agonist-mediated Down-regulation, Journal of Biological Chemistry, 10.1074/jbc.M304482200, 278:41, (39773-39781), Online publication date: 1-Oct-2003. Xiang Y and Kobilka B (2003) Myocyte Adrenoceptor Signaling Pathways, Science, 10.1126/science.1079206, 300:5625, (1530-1532), Online publication date: 6-Jun-2003. Tuček S, Michal P and Vlachová V (2002) Modelling the consequences of receptor–G-protein promiscuity, Trends in Pharmacological Sciences, 10.1016/S0165-6147(00)01996-9, 23:4, (171-176), Online publication date: 1-Apr-2002. See Hoe L, Bartnikowski N, Wells M, Suen J and Fraser J (2019) Hurdles to Cardioprotection in the Critically Ill, International Journal of Molecular Sciences, 10.3390/ijms20153823, 20:15, (3823) October 13, 2000Vol 87, Issue 8 Advertisement Article InformationMetrics © 2000 American Heart Association, Inc.https://doi.org/10.1161/01.RES.87.8.635 Originally publishedOctober 13, 2000 Keywordsβ-adrenergic receptor subtypescAMP compartmentalizationdual G protein couplingheart failurePDF download Advertisement